EVRA-CEL
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Mar 2024)
What this means for you
This application is over — abandoned 11 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97238048
- Mark type
- Stylized text
- Filed
- 25 Jan 2022
- Published for opposition
- 13 Dec 2022
- Abandoned
- 11 Mar 2024
- Attorney of record
- Jesse A. Salen
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
Owner
- Atara Biotherapeutics, Inc., Thousand Oaks, CA, US
- Atara Biotherapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 11 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2023 — SOU EXTENSION 1 GRANTED
- 01 Aug 2023 — SOU EXTENSION 1 FILED
- 01 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 24 May 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 May 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Feb 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2022 — ASSIGNED TO EXAMINER